Positive Phase 2 Clinical Trial Results Of Piromelatine For Treatment Of Insomnia
Neurim Pharmaceuticals has announced positive results from a phase II clinical study evaluating the efficacy and safety of Piromelatine (Neu-P11), a novel investigational multimodal sleep medicine…